InvestorsHub Logo
Followers 7
Posts 379
Boards Moderated 0
Alias Born 12/11/2016

Re: falconer66a post# 361476

Friday, 05/27/2022 8:23:25 AM

Friday, May 27, 2022 8:23:25 AM

Post# of 462151
In Pharma trials, is it possible to submit a NDA based on secondary endpoint being successful? Sleep in all of these trials has always been a secondary endpoint, so I'm just wondering based on the hundreds of trial patient's data, in different treatment disorders, would Anavex be able to combine sleep therapy as an NDA?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News